These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 74175)

  • 21. Malignant lymphoma and chronic lymphatic leukaemia with atypical lung involvement--a case report.
    Singh A; Singh H
    Indian J Chest Dis; 1971 Jul; 13(3):123-4. PubMed ID: 5119385
    [No Abstract]   [Full Text] [Related]  

  • 22. [Delayed hypersensitivity and lymphocyte in vitro cultures in a case of chronic lymphoid leukemia preceded by renal tuberculosis].
    Omodei Zorini C; Neri A
    Folia Allergol (Roma); 1968; 15(6):431-7. PubMed ID: 5733483
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic lymphatic leukemia].
    Streuli RA
    Schweiz Rundsch Med Prax; 1986 Apr; 75(15):415-20. PubMed ID: 3485811
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the cell populations in chronic lymphocytic leukaemia (author's transl)].
    Montserrat Costa E; Matamoros N; Vives-Puiggros J; Rozman C
    Sangre (Barc); 1976; 21(3):477-84. PubMed ID: 968712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Features of cellular immunity of chronic lympholeukemia].
    Sinitsina AM; Zverkova AS
    Vrach Delo; 1982; (10):49-51. PubMed ID: 6983781
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
    Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
    J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reactivity of lymphocytes in chronic lymphatic leukemia].
    Radeva M; Stoichkov I; Petrov M; Marinova S
    Vutr Boles; 1972; 11(3):67-70. PubMed ID: 4679982
    [No Abstract]   [Full Text] [Related]  

  • 28. The immune response to phichi174 in man. IV. Primary and secondary antibody production in patients with chronic lymphatic leukaemia.
    Hamblin TJ; Jones JV; Peacock DB
    Clin Exp Immunol; 1975 Jul; 21(1):101-8. PubMed ID: 810280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the cellular immunocompetence in chronic lymphatic leukemia and malignant lymphoma patients as assessed by the local graft versus host reaction in rats.
    Shohat B; Joshua H; Ben-Bassat M
    J Reticuloendothel Soc; 1974 Nov; 16(5):276-81. PubMed ID: 4155447
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phenotype characterization of chronic lymphatic leukemia with monoclonal antibodies and membrane receptors].
    Estevez ME; Sen L; Diez RA; Bellouard A; Santos I
    Medicina (B Aires); 1981; 41 Suppl():123-30. PubMed ID: 7047978
    [No Abstract]   [Full Text] [Related]  

  • 31. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Observation of surface markers of leukemic cells in three cases of chronic lymphatic leukemia (author's transl)].
    Park K; Kamitani T; Tatsumi Y; Im T; Tatsumi N; Kimura Y; Mahda H; Okuda K; Yamamoto S
    Rinsho Ketsueki; 1982 Jan; 23(1):91-9. PubMed ID: 6980302
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic value of mouse red cell rosette formation in chronic lymphocytic leukaemia.
    Bertoglio J; Peaud PY; Bryon PA; Treille D; Felman P; Doré JF
    Biomedicine; 1976 Sep; 25(8):277-8. PubMed ID: 793646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of macrophages on periodate-induced transformation of normal and chronic lymphatic leukaemia lymphocytes.
    Biniaminov M; Ramot B; Novogrodsky A
    Clin Exp Immunol; 1974 Feb; 16(2):235-42. PubMed ID: 4377711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukaemia with raised serum IgM levels.
    Ukaejiofo EO; Onwukeme KE; Sagoe AS; Esan GJ
    Afr J Med Med Sci; 1987 Sep; 16(3):113-8. PubMed ID: 2829603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of supernatant from PHA-stimulated lymphocyte culture on blastic transformation of peripheral blood lymphocytes in healthy controls and patients with chronic lymphatic leukemia].
    Pluzańska A; Kaluzna W
    Acta Haematol Pol; 1976; 7(3):231-5. PubMed ID: 983671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of anti-erythrocytic antibodies in cases of malignant lymphogranuloma and chronic lymphatic leukemia.
    PAOLINO W; RICCI C
    Riv Emoter Immunoematol; 1957; 4(6):430-1. PubMed ID: 13528650
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibodies to DNA in the serum of patients with chronic lymphatic leukemia].
    Stefani NV
    Probl Gematol Pereliv Krovi; 1971; 16(4):31-3. PubMed ID: 5120490
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical importance of blastic transformation of lymphocytes in chronic lymphatic leukemia].
    Holowiecki J
    Acta Haematol Pol; 1972; 3(3):237-43. PubMed ID: 4649306
    [No Abstract]   [Full Text] [Related]  

  • 40. PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
    Robert KH
    Clin Exp Immunol; 1979 Sep; 37(3):517-22. PubMed ID: 315847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.